all stories

Larimar Therapeutics (NASDAQ:LRMR) Director Frank Thomas Acquires 8,000 Shares of Stock

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Fri, 13 November 2026

What it is about

Frank ThomasNasdaqSecurities Exchange CommissionDimensional Fund AdvisorsCapital ManagementRenaissance TechnologiesLarimar Therapeutics Company ProfileBala Cynwyd, Pennsylvania, United StatesPennsylvania, United StatesBlackrock, Pennsylvania, United States

Who published it, and when

How it spread - 1 original report

  1. Fri, 13 November 2026

    1 report
    • dailypolitical.com01:30first to report

      Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) Director Frank Thomas purchased 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 11th. The shares were acquired at an average price of $2.73 per share, for a total transaction of $21,840.00. Following the completion of the acquisition, the director directly owned […]

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.